Increase in potential activities of protein phosphatases PP1 and PP2A in lymphoid tissues of autoimmune MRL/MpJ-lpr/lpr mice.
The differential assay conditions for protein phosphatases PP1, PP2A, and PP2C were extensively studied by using crude extracts from mouse lymphoid tissues as enzyme sources. Under these conditions, the protein phosphatase activities were measured in MRL/MpJ-lpr/lpr mice (MRL/lpr mice), autoimmune-prone mice, and MRL/MpJ(-)+/+ mice (MRL/+/+ mice) and C3H/HeJ mice as the controls. In MRL/lpr mice, significant alterations in protein phosphatase activities from those in the control mice were demonstrated. In spleen and liver from MRL/lpr mice, potential activities of PP1 and PP2A were distinctly elevated over those of the control mice. These elevations appeared to be due to accumulation of the abnormal lymphocytes that emerged in MRL/lpr mice. Although the PP1 activity in MRL/lpr lymph nodes was lower than those of normal spleen and thymus, it was greatly increased by Co(2+)-trypsin treatment so that the PP1 activity of MRL/lpr lymph nodes was the highest among those of all the tissues examined. In contrast, PP2C activity showed no remarkable alteration in the autoimmune disease model mice as compared with that in the control mice. These results demonstrated a specific elevation in potency of protein dephosphorylation in the tissues of MRL/lpr mice, suggesting a new explanation for the defect in signal transduction in this disease.
Matsuzawa
S
S
Section of Biochemistry, Hokkaido University.
Tamura
T
T
Mizuno
Y
Y
Kobayashi
S
S
Okuyama
H
H
Tsukitani
Y
Y
Uemura
D
D
Kikuchi
K
K
D000818:Animals; D001327:Autoimmune Diseases / Q000201:enzymology* / Q000235:genetics; D015551:Autoimmunity / Q000235:genetics / Q000502:physiology*; D000431:Ethanol / Q000494:pharmacology; D004988:Ethers, Cyclic / Q000494:pharmacology; D005260:Female; D007527:Isoenzymes / Q000037:antagonists & inhibitors / Q000378:metabolism*; D008221:Lymphoid Tissue / Q000201:enzymology*; D051379:Mice; D008815:Mice, Inbred Strains; D019319:Okadaic Acid; D009994:Osmolar Concentration; D010749:Phosphoprotein Phosphatases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D014357:Trypsin / Q000494:pharmacology
D004988:Ethers, Cyclic; D007527:Isoenzymes; D019319:Okadaic Acid; D000431:Ethanol; D010749:Phosphoprotein Phosphatases; D014357:Trypsin